Cicely Hooten
Psychiatric/Mental Health · Glendale, CONPI 1073003018
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,714 and has fallen 90.7% since, to $160 in 2024. Among psychiatric/mental health clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$403
- Alkermes, Inc.$333
- Vanda Pharmaceuticals Inc.$241
- AstraZeneca$210
- Amgen$143
- Bausch Health US, LLC$141
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,62298%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $403 |
| Alkermes, Inc. | 12 | $333 |
| Vanda Pharmaceuticals Inc. | 9 | $241 |
| AstraZeneca | 3 | $210 |
| Amgen(2 entities) | 2 | $143 |
| Bausch Health US, LLC | 7 | $141 |
| Otsuka America Pharmaceutical, Inc. | 10 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 3 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $102 |
| Indivior Inc. | 3 | $97 |
| Novo Nordisk | 1 | $90 |
| Johnson & Johnson | 4 | $77 |
| Acadia Pharmaceuticals Inc | 2 | $69 |
| Eisai Inc. | 4 | $60 |
| Lundbeck LLC | 3 | $58 |
| Neurocrine Biosciences, Inc. | 4 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$102
How this compares
$2,669 in reported general payments places this provider in the 90th percentile of 873 psychiatric/mental health providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $692 |
| Buspirone Hcl | 24 | $276 |
| Trazodone Hcl | 21 | $211 |
| Quetiapine Fumarate | 12 | $169 |
| Duloxetine Hcl | 14 | $162 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Glendale
- Joseph CrowleyGlendale$11K
- Chelsie MonroeLittleton$998K
- Audrey StrockDenver$499K
- Pinkie FittsAurora$444K
- Mark JankelowColorado Springs$287K
- Cristi BundukamaraColorado Springs$230K
- Deborah YorkDenver$158K
- Shelley AbadiLakewood$19K
- James AndersonWheat Ridge$18K
- Eliza MarroniGrand Junction$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.